Calumet targets 200m gallons of SAF in 2028 as it outlines $30m annual MRL lease payments to CMR (NASDAQ:CLMT)

Calumet Inc. (CLMT) reported $347M adjusted EBITDA for Q3 2026, with CEO Louis Borgmann calling it an exceptional quarter. The company aims to produce 200M gallons of sustainable aviation fuel (SAF) by 2028 and expects $30M annual minimum lease payments to CMR.

Original reporting

seekingalpha.com

Published Nov 6, 2026, 6:25 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Nov 6, 2026, 6:29 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefEarnings

Primary signal

$CLMT

Bullish

high confidence

Mentioned

$CLMT

Relevance

8/10

AlphAI data visualization · based on seekingalpha.com

Decision brief

The 30-second read

$CLMTBullishMed

Why it matters

The earnings beat expectations, indicating strong operational performance and may trigger short‑term buying interest.

Market read

The earnings release provides fresh material data that could move CLMT and influence sector sentiment.

What to watch

Potential headwinds from raw material costs and regulatory changes in the chemicals industry.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Calumet, Inc. (NASDAQ:CLMT) reported its Q3 2026 earnings, highlighting adjusted EBITDA of $347 million.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CLMTBullishHigh confidence

Context

Q3 2026 earnings call disclosed $347 million of adjusted EBITDA, a fresh material earnings figure for Calumet.

Expected impact

likely upward pressure as the market prices in the strong earnings performance

Evidence & confidence

The disclosed EBITDA exceeds prior expectations and is the first public report of the quarter's results.

Market effects

Sector

May boost sentiment in the specialty chemicals sector.

Regional

Positive for U.S. mid‑cap industrial stocks.

Global

Limited to investors tracking Calumet and related peers.

Counterpoint

What could challenge this read

If the EBITDA growth is not sustainable, the stock could face a pull‑back once detailed guidance is released.

Key entities

Company
Calumet, Inc.
U.S. specialty chemicals producer.

Read at source ← All news

$CLMTMed

What Calumet (CLMT) Said on Its Q3 Earnings Call

Calumet (CLMT) reported Q3 earnings, highlighting a completed turnaround at its Shreveport facility and progress on Montana Renewables' expansion. Adjusted EBITDA for Montana Renewables was $110.6M, with CMR contributing $40.8M. The company plans to increase sustainable aviation fuel production, with a path to 200M gallons annually by 2028. Debt reduction remains a priority, with $175M in 2028 notes outstanding.

finance.yahoo.comNov 6

$CLMTHighAI 8/10

Calumet Reports $273.3 Million Q3 Net Income and $347.2 Million Adjusted EBITDA

Calumet reported Q3 2026 net income of $273.3M, down from $313.4M a year earlier. Revenue rose to $1.68B, with adjusted EBITDA at $322.0M ($347.2M with tax attributes). The company reduced debt by $265M since July. Sales growth was driven by specialty products and renewables, while margins varied across segments.

tradingview.comNov 6

$CLMTHighAI 8/10

Calumet Reports Third Quarter 2026 Results

Calumet, Inc. /DE (CLMT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Calumet Reports Third Quarter 2026 Results • Third Quarter 2026 net income of $273.3 million, or basic earnings per common share of $2.91 • Third Quarter 2026 Adjusted EBITDA with Tax Attributes of $347.2 million • Accelerated deleveraging continues with approximatel

SEC EDGAR 8-KNov 6

$CLMTMedAI 8/10

Calumet earnings beat by $1.36, revenue topped estimates

Calumet (CLMT) reported Q3 EPS of $2.91, beating estimates by $1.36, with revenue at $1.68B, topping consensus of $1.26B. Stock is down 4.66% in 3 months but up 125.90% in 12 months. InvestingPro rates its financial health as 'fair performance'.

investing.comNov 6

$CLMTMedAI 9/10

Calumet (NASDAQ:CLMT) delivers impressive Q3 2026, stock soars

Calumet (CLMT) reported Q3 2026 revenue of $1.68 billion, beating estimates by 25.3%, and EPS of $2.91, surpassing forecasts by 73.9%. Adjusted EBITDA was $347.2 million, a 31.5% beat. Operating margin decreased to 27% while free cash flow margin increased to 9.6%.